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intracerebral hemorrhage
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Abstract
Background: The toxicity of heme breakdown products may contribute to the pathogenesis of intracerebral
hemorrhage (ICH). Heme catabolism is catalyzed by the heme oxygenase enzymes. We have previously reported
that heme oxygenase-2 (HO-2), the constitutive isoform, protects neurons from hemin in vitro and reduces oxidative
stress after striatal blood injection. In order to further evaluate HO-2 as a therapeutic target, we tested the hypothesis
that HO-2 gene deletion protects neurons and attenuates behavioral deficits after ICH.
Findings: Injection of 20 μl blood into the right striatum of HO-2 wild-type mice resulted in loss of approximately one
third of striatal neurons 4-8 days later. Neuronal survival was significantly increased in HO-2 knockout mice at both time
points. This was associated with reduced motor deficit as detected by the corner test; however, no differences were
detected in spontaneous activity or the adhesive removal or elevated body swing tests.
Conclusion: HO-2 knockout attenuates perihematomal neuron loss in the blood injection ICH model, but has a weak
and variable effect on neurological outcome.
Findings
Background
The heme oxygenase (HO) enzymes catalyze breakdown
of heme to biliverdin, carbon monoxide, and ferrous
iron. Parenchymal heme is present in abundance after
intracerebral hemorrhage (ICH), and so the effect of
these enzymes has been the subject of considerable re-
search interest. The unavailability of selective and spe-
cific HO inhibitors has necessitated the use of knockout
mice for these studies. Wang et al. reported that mice
lacking HO-1, the inducible isoform, sustained less peri-
hematomal injury after collagenase-induced ICH. This
was associated with a reduction in the inflammatory res-
ponse, but only a transient improvement in neurological
outcome [1]. We have previously reported that HO-2
knockout protected murine neurons in vitro from he-
moglobin or hemin [2,3], and attenuated oxidative injury
markers after hemoglobin or blood injection into the
striatum [4,5]. However, when ICH was produced by col-
lagenase injection, HO-2 knockout either increased local
cell injury or had no effect, while increasing neurological
deficits to a variable extent [6,7].
The animal model that is most representative of clinical
ICH is undefined and somewhat controversial, necessitat-
ing evaluation of pharmacologic and genetic interventions
in both models [8]. The negative effect of HO-2 knockout
in the collagenase model indicated the need for further as-
sessment of its impact in the blood injection model. In the
present experiments, we used a recently-validated fluores-
cent method to quantify neuron loss in HO-2 wild-type
and knockout mice after striatal injection of autologous
blood. We also evaluated the effect of HO-2 knockout on
neurological outcome, which had never been reported in
this model.
Methods
a) Experimental animals
All breeding and procedures were conducted following
protocols approved by the Thomas Jefferson University
Institutional Animal Care and Use Committee. Mice used
in this study were bred in our animal care facility and
expressed the red fluorescent protein variant dTomato in* Correspondence: Raymond.Regan@jefferson.edu
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neurons [9]; recent experiments demonstrated that loss of
dTomato fluorescence correlated well with neuron loss
adjacent to a striatal hematoma [6]. Mice were crossed
with homozygous HO-2 knockout mice (C57BL/6 x129/
Sv background); heterozygous HO-2 knockout mice were
then bred to obtain HO-2 WT and knockout mice. Prior
experiments had demonstrated that neuronal dTomato
expression had no effect on behavioral phenotype in either
WT or HO-2 KO mice [6].
b) Striatal blood injection
Mice (n = 34, 18 males, 16 females) were 4-6 months old
when used. Striatal blood injection (20 μl total volume)
was conducted as previously described under 1.5% iso-
flurane anesthesia [10]. Temperature was monitored
with a rectal probe and maintained at 37.0 ± 0.5 degrees
with a heating lamp.
c) Striatal injury quantification
Striatal neuron loss was assessed 4 and 8 days after blood
injection by dTomato fluorescence assay [6]. Striatal cell
viability was quantified on the same samples via MTT
assay [4,5]. Both measures correlate well with more labo-
rious counts of striatal neurons on histological sections
using stereological methods [6]. After cervical dislocation
under deep isoflurane anesthesia, brains were rapidly re-
moved; injected and contralateral striata were immediately
excised and dissociated separately by trituration. The cell
suspension was incubated with 0.25 mg/ml MTT at 37°C
for four minutes. After collection by low speed centrifuga-
tion, the formazan product was extracted in 2 ml isopro-
panol, and absorbance of this solution was determined
(562 nm). Cells were again collected by centrifugation and
sonicated in 500 μl PBS to release dTomato. Fluorescence
(ex 557 nm, em 585 nm) was then quantified. Absorbance
and fluorescence values were normalized to those in
contralateral striata.
d) Behavioral testing
Neurological deficits were assessed by a blinded obser-
ver as previously detailed [6], via: 1) Digital analysis of
spontaneous activity in a 3 hour video recording by
HomeCageScan (Version 3.0, Clever Systems Inc., Reston,
VA USA); 2) Corner test, right striatal injury produces a
right turning bias [11]; 3) Adhesive removal test [12]; 4)
Elevated body swing test, right striatal injury produces a
left swinging bias [13].
e) Statistical analysis
Differences between wild-type and knockout groups were
assessed via unpaired t-test using GraphPad software.
Results
a) HO-2 knockout reduces perihematomal injury
In HO-2 WT mice, striatal dTomato fluorescence at 4
and 8 days after blood injection was 58.8 ± 3.4% and
63.5 ± 3.1% of contralateral, respectively (Figure 1). In
HO-2 KO mice, this value was significantly increased at
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Figure 1 Right striatal cell injury 4 and 8 days after blood
injection, quantified by MTT assay (Formazan) and extracted
dTomato fluorescence, in HO-2 wild-type and KO mice. All
values (mean ± S.E.M, n = 7-9/condition) are normalized to those in
the contralateral striatum (=100). *P < 0.05, **P < 0.01 v. corresponding
WT condition. Scatter plot demonstrates correlation between MTT and
dTomato assay results.
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both time points. Consistent with prior observations [6],
the percentage change in dTomato expression in injec-
ted striata was in close agreement with the decrease in
MTT conversion to formazan.
b) Effect of HO-2 knockout on behavioral recovery
Injection of blood into the right striatum produced focal
left sided deficits and a reduction in spontaneous cage
activity at Day 3, with partial recovery noted by Day 7
(Figure 2). A significant difference between HO-2 WT
and KO groups was observed only at day 7 in the corner
test. HO-2 KO did not have a significant effect on recov-
ery of spontaneous cage activity, or on focal sensorimotor
deficits as detected by adhesive removal or elevated body
swing tests.
Discussion
This study serves two purposes. First, we have demon-
strated the neuroprotective effect of HO-2 knockout in
this ICH model, using a novel fluorescent method to
quantify perihematomal neuron loss. Second, we present
data indicating that this cytoprotection was associated
with a rather weak and variable improvement in behavio-
ral outcome.
Accurate assessment of cell death in tissue surround-
ing an experimental hematoma is complicated by the
heterogeneity of the injury. In contrast to the infarction
produced in ischemic stroke models, an experimental
hematoma is surrounded by areas of variable neurode-
generation [14]. This presents considerable challenges to
section and field selection when cell loss is quantified by
traditional histological methods. Accurate and unbiased
results can be obtained with design-based stereology, but
this approach is expensive, laborious, and rarely employed
in ICH studies. Using the collagenase ICH model, we have
recently reported that striatal neuron loss can be accur-
ately estimated in mice expressing neuronal dTomato by
simply measuring the fluorescence of a tissue lysate [6].
The present study uses this approach for the first time in
the blood injection ICH model. Striatal fluorescence mea-
surements correlated closely with cell viability as mea-
sured with the MTT assay, a method that has previously
been validated with stereological cell counts [6].
The neuroprotective effect of HO-2 knockout in this
model is consistent with our prior findings that it attenu-
ated protein and lipid oxidation after striatal hemoglobin
or blood injection [4,5]. The disparate effect of HO-2
knockout in the collagenase and blood injection models
likely reflects the predominance of differing injury mecha-
nisms in these models. When equal hematoma volumes
were compared, a collagenase-induced ICH produced sig-
nificantly more blood-brain barrier injury and edema [15].
Disruption of multiple vessels near the injection site may
also produce ischemia, which is not a feature of the blood
Figure 2 Effect of HO-2 knockout on behavioral deficits in
striatal blood injection model. Sensorimotor deficits were assessed
by corner test (right striatal injury causes turn to right), elevated
body swing test (injury causes left swing), adhesive removal test,
and digital analysis of spontaneous activity, n = 8-13/condition,
*P < 0.05 v. corresponding WT condition.
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injection ICH model [16] and has not been observed in
blood flow studies of patients sustaining an ICH [17]. It is
possible that any benefit of HO-2 knockout on the heme-
mediated component of injury after collagenase-induced
ICH is negated by its deleterious effect on ischemic injury,
as previously reported by Doré et al. [18].
Since neurological outcome will be the key measure of
efficacy in any clinical trial, identification of a thera-
peutic target for ICH requires clear and convincing dem-
onstration of functional improvement in experimental
models. To date, that standard has not been met for ei-
ther HO isoform. Studies by Wang and Doré demon-
strated that HO-1 KO improved the neurologic score at
24 hours after collagenase injection but not at later time
points, suggesting a limited utility of targeting HO-1 alone
[1]. HO-2 knockout has had variable but negative effects
on behavioral outcome after collagenase-induced ICH
[6,7], and a weak benefit in the present study. Concomi-
tant inhibition of both HO-1 and HO-2 with porphyrin
HO inhibitors reduced edema and neuronal loss after ex-
perimental ICH, and may be more effective than targeting
a single isoform [19-21]. Although the nonspecificity of
these compounds limits their value as mechanistic probes,
further investigation of their effects on neurological out-
come in both ICH models seems warranted.
Conclusion
HO-2 knockout attenuates perihematomal neuron loss
in this murine blood injection ICH model, but has a
weak and variable effect on neurological outcome. These
results do not support the utility of therapies that target
HO-2 activity or expression per se after ICH.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JCR performed all stereotactic injections and dTomato/MTTassays, and
participated in drafting the manuscript. YC carried out all behavioral assays.
RFR designed the study and participated in drafting the manuscript. All
authors assisted in data analysis, and read and approved the final
manuscript.
Acknowledgements
Financial support for this research was provided by NIH grants (NS074289
and NS079500) to R.F.R.
Received: 21 April 2014 Accepted: 31 July 2014
Published: 22 August 2014
References
1. Wang J, Doré S: Heme oxygenase-1 exacerbates early brain injury after
intracerebral haemorrhage. Brain 2007, 130:1643–1652.
2. Rogers B, Yakopson V, Teng ZP, Guo Y, Regan RF: Heme oxygenase-2
knockout neurons are less vulnerable to hemoglobin toxicity. Free Rad
Biol Med 2003, 35:872–881.
3. Regan RF, Chen J, Benvenisti-Zarom L: Heme oxygenase-2 gene deletion
attenuates oxidative stress in neurons exposed to extracellular hemin.
BMC Neurosci 2004, 5:34.
4. Qu Y, Chen J, Benvenisti-Zarom L, Ma X, Regan RF: Effect of targeted
deletion of the heme oxygenase-2 gene on hemoglobin toxicity in the
striatum. J Cereb Blood Flow Metab 2005, 25:1466–1475.
5. Qu Y, Chen-Roetling J, Benvenisti-Zarom L, Regan RF: Attenuation of
oxidative injury after induction of experimental intracerebral
hemorrhage in heme oxygenase-2 knockout mice. J Neurosurg 2007,
106:428–435.
6. Chen-Roetling J, Lu X, Regan KA, Regan RF: A rapid fluorescent method to
quantify neuronal loss after experimental intracerebral hemorrhage.
J Neurosci Methods 2013, 216:128–136.
7. Wang J, Zhuang H, Doré S: Heme oxygenase 2 is neuroprotective against
intracerebral hemorrhage. Neurobiol Dis 2006, 22:473–476.
8. Kirkman MA, Allan SM, Parry-Jones AR: Experimental intracerebral
hemorrhage: avoiding pitfalls in translational research. J Cereb Blood Flow
Metab 2011, 31:2135–2151.
9. Livet J, Weissman TA, Kang H, Draft RW, Lu J, Bennis RA, Sanes JR, Lichtman JW:
Transgenic strategies for combinatorial expression of fluorescent proteins
in the nervous system. Nature 2007, 450:56–62.
10. Chen L, Zhang X, Chen-Roetling J, Regan RF: Increased striatal injury and
behavioral deficits after intracerebral hemorrhage in hemopexin
knockout mice. J Neurosurg 2011, 114:1159–1167.
11. Zhang L, Schallert T, Zhang ZG, Jiang Q, Arniego P, Li Q, Lu M, Chopp M:
A test for detecting long-term sensorimotor dysfunction in the mouse
after focal cerebral ischemia. J Neurosci Methods 2002, 117:207–214.
12. MacLellan CL, Auriat AM, McGie SC, Yan RH, Huynh HD, De Butte MF,
Colbourne F: Gauging recovery after hemorrhagic stroke in rats:
implications for cytoprotection studies. J Cereb Blood Flow Metab 2006,
26:1031–1042.
13. Liu DZ, Cheng XY, Ander BP, Xu H, Davis RR, Gregg JP, Sharp FR: Src kinase
inhibition decreases thrombin-induced injury and cell cycle re-entry in
striatal neurons. Neurobiol Dis 2008, 30:201–211.
14. Hua Y, Keep RF, Hoff JT, Xi G: Brain injury after intracerebral hemorrhage:
the role of thrombin and iron. Stroke 2007, 38:759–762.
15. MacLellan CL, Silasi G, Poon CC, Edmundson CL, Buist R, Peeling J,
Colbourne F: Intracerebral hemorrhage models in rat: comparing
collagenase to blood infusion. J Cereb Blood Flow Metab 2008, 28:516–525.
16. Qureshi AI, Wilson DA, Hanley DF, Traystman RJ: No evidence for an
ischemic penumbra in massive experimental intracerebral hemorrhage.
Neurology 1999, 52:266–272.
17. Zazulia AR, Diringer MN, Videen TO, Adams RE, Yundt K, Aiyagari V, Grubb
RL Jr, Powers WJ: Hypoperfusion without ischemia surrounding acute
intracerebral hemorrhage. J Cereb Blood Flow Metab 2001, 21:804–810.
18. Doré S, Sampei K, Goto S, Alkayed NJ, Guastella D, Blackshaw S, Gallagher
M, Traystman RJ, Hurn PD, Koehler RC, Snyder SH: Heme oxygenase-2 is
neuroprotective in cerebral ischemia. Mol Med 1999, 5:656–663.
19. Wagner KR, Hua Y, de Courten-Myers GM, Broderick JP, Nishimura RN, Lu SY,
Dwyer BE: Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for
treatment of intracerebral hemorrhage: in vivo and in vitro studies.
Cell Mol Biol 2000, 46:597–608.
20. Koeppen AH, Dickson AC, Smith J: Heme oxygenase in experimental
intracerebral hemorrhage: the benefit of tin-mesoporphyrin.
J Neuropathol Exp Neurol 2004, 63:587–597.
21. Gong Y, Tian H, Xi G, Keep RF, Hoff JT, Hua Y: Systemic zinc
protoporphyrin administration reduces intracerebral hemorrhage-
induced brain injury. Acta Neurochir Suppl 2006, 96:232–236.
doi:10.1186/1756-0500-7-561
Cite this article as: Chen-Roetling et al.: Neuroprotective effect of heme
oxygenase-2 knockout in the blood injection model of intracerebral
hemorrhage. BMC Research Notes 2014 7:561.
Chen-Roetling et al. BMC Research Notes 2014, 7:561 Page 4 of 4
http://www.biomedcentral.com/1756-0500/7/561
